Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $700 Million of Convertible Senior Notes due 2027 ...Middle East

SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), a leader in converting IV biologics to subcutaneous delivery, today announced the pricing of $700 million aggregate principal amount of its convertible senior notes due 2027...

Hence then, the article about halozyme therapeutics inc announces pricing of private offering of 700 million of convertible senior notes due 2027 was published today ( Thursday 25/02/2021 - 07:47 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $700 Million of Convertible Senior Notes due 2027 )

Also on site :

• A Recent Tragedy Has Left My Kids Devastated. But I’m Secretly Pleased.
• Watch last video of ‘All That’ star Kianna Underwood who died in hit-and-run at 33
• Refugee-student housing project in EU state rocked by rape scandal